Hematopathology [electronic resource] :Genomic Mechanisms of Neoplastic Diseases / edited by Domnita Crisan.
by Crisan, Domnita [editor.]; SpringerLink (Online service).
Material type:
BookSeries: Molecular and Translational Medicine: Publisher: Totowa, NJ : Humana Press : 2011.Description: XII, 360 p. online resource.ISBN: 9781607612629.Subject(s): Medicine | Hematology | Oncology | Pathology | Medicine & Public Health | Pathology | Hematology | Molecular Medicine | OncologyDDC classification: 616.07 Online resources: Click here to access online | Item type | Current location | Call number | Status | Date due | Barcode |
|---|---|---|---|---|---|
| MAIN LIBRARY | RB1-214 (Browse shelf) | Available |
Browsing MAIN LIBRARY Shelves Close shelf browser
| R895-920 Dating Neurological Injury: | RJ1-570 Pediatric Interviewing | RC870-923.2 Management of Prostate Cancer | RB1-214 Hematopathology | RC321-580 New Strategies in Stroke Intervention | RB1-214 Pharmacogenomic Testing in Current Clinical Practice | RC321-580 Mammalian Brain Development |
Chapter 1: Molecular techniques used in Hematopathology -- Chapter 2: Cytogenetics techniques used in Hematopathology -- Chapter 3: The molecular component of the new WHO classification of hematologic malignancies -- Chapter 4: Molecular pathology of pediatric acute leukemias -- Chapter 5: Molecular pathology of adult acute leukemias -- Chapter 6: Molecular pathology of lymphomas -- Chapter 7: Molecular pathology of chronic myeloproliferative neoplasms -- Chapter 8: Molecular pathology of CLL -- Chapter 9: Targeted therapy in hematologic malignancies -- Chapter 10: MicroRNAs in hematologic malignancies.
Hematopathology: Genomic Mechanisms of Neoplastic Diseases will keep physicians abreast of the rapid and complex changes in genomic medicine, as exemplified by the molecular pathology of hematologic malignancies. This timely volume will update physicians on the complexities of genomic lesions, as well as offer an integrated framework encompassing molecular diagnosis, the new WHO classification of hematologic neoplasms with focus on molecular pathology, prognostic value of molecular tests, and molecular monitoring of response to gene-targeted therapy. As such, it will be of great value to hematologists, oncologists, pathologists, internal medicine and pediatric specialists, as well as bioscientific staff and laboratorians in private hospitals and academic institutions.
There are no comments for this item.